Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Browse by collection
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Browse by collection
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 99, Issue 8
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical science
UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12
Free
Online download statistics by month:
Online download statistics by month: February 2015 to February 2023
Abstract
Full
Pdf
Feb 2015
251
18
33
Mar 2015
128
23
31
Apr 2015
68
7
12
May 2015
27
5
8
Jun 2015
51
9
18
Jul 2015
653
57
57
Aug 2015
635
80
76
Sep 2015
244
55
39
Oct 2015
129
14
28
Nov 2015
116
27
37
Dec 2015
100
21
9
Jan 2016
91
20
14
Feb 2016
74
19
22
Mar 2016
47
6
14
Apr 2016
56
4
6
May 2016
47
11
10
Jun 2016
47
9
16
Jul 2016
59
13
21
Aug 2016
40
5
14
Sep 2016
39
4
8
Oct 2016
42
5
9
Nov 2016
41
5
16
Dec 2016
42
11
1
Jan 2017
49
4
4
Feb 2017
16
19
9
Mar 2017
13
11
7
Apr 2017
8
20
8
May 2017
16
27
12
Jun 2017
20
26
11
Jul 2017
63
39
10
Aug 2017
71
38
14
Sep 2017
104
87
2
Oct 2017
228
208
5
Nov 2017
129
79
9
Dec 2017
169
78
4
Jan 2018
151
61
4
Feb 2018
114
68
4
Mar 2018
321
242
4
Apr 2018
87
68
5
May 2018
115
80
9
Jun 2018
93
75
2
Jul 2018
118
104
1
Aug 2018
131
109
4
Sep 2018
110
110
5
Oct 2018
111
109
5
Nov 2018
88
88
1
Dec 2018
90
90
2
Jan 2019
92
81
2
Feb 2019
75
69
4
Mar 2019
29
26
7
Apr 2019
24
21
7
May 2019
25
26
8
Jun 2019
55
48
12
Jul 2019
48
42
6
Aug 2019
45
44
4
Sep 2019
47
45
7
Oct 2019
40
40
5
Nov 2019
36
34
4
Dec 2019
50
45
2
Jan 2020
43
42
4
Feb 2020
41
41
5
Mar 2020
28
28
3
Apr 2020
47
41
2
May 2020
78
68
16
Jun 2020
63
57
16
Jul 2020
57
53
7
Aug 2020
42
40
6
Sep 2020
60
49
7
Oct 2020
58
48
14
Nov 2020
19
11
5
Dec 2020
59
47
7
Jan 2021
22
16
5
Feb 2021
19
17
8
Mar 2021
12
9
6
Apr 2021
16
11
3
May 2021
16
11
4
Jun 2021
9
8
4
Jul 2021
12
11
14
Aug 2021
7
5
8
Sep 2021
15
14
12
Oct 2021
13
12
16
Nov 2021
13
8
19
Dec 2021
18
11
8
Jan 2022
10
8
2
Feb 2022
24
20
7
Mar 2022
35
23
12
Apr 2022
27
17
5
May 2022
26
24
15
Jun 2022
31
25
4
Jul 2022
21
19
6
Aug 2022
39
31
4
Sep 2022
37
26
29
Oct 2022
49
25
9
Nov 2022
14
12
10
Dec 2022
13
9
4
Jan 2023
23
17
14
Feb 2023
20
18
4
Total
7144
3721
1032
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via AAO
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?